Device Software and Data Collection Transparency

Apr 25, 2023 | White Paper |

Device Software and Data Collection TransparencyDecentralized clinical trials (DCTs) are becoming more and more popular as a means of improving patient access and participation, reducing costs, and increasing efficiency. However, DCTs also present unique challenges in terms of data collection and management, particularly when it comes to maintaining transparency and ensuring data quality. 

In this paper, we delve into the importance of data collection transparency in DCTs, the device software that will be utilized, and propose a framework for achieving transparency while also maintaining patient privacy and confidentiality. By adhering to this framework, DCTs can improve the reliability and trustworthiness of their data, and ultimately help to advance the development of new treatments and therapies.

To learn more, click to read the latest MEDIcept White Paper.